200,000+ products from a single source!
sales@angenechem.com
CAS No: 14805-64-2 Catalog No: AG001FF4 MDL No:MFCD04114413
Title | Journal |
---|---|
Solid-phase synthesis of naphthylamidines as factor VIIa/tissue factor inhibitors. | Bioorganic & medicinal chemistry letters 20050502 |
Naphthamidine urokinase plasminogen activator inhibitors with improved pharmacokinetic properties. | Bioorganic & medicinal chemistry letters 20050103 |
Inhibition of human immunodeficiency virus type I integrase by naphthamidines and 2-aminobenzimidazoles. | Antiviral research 20041001 |
Design, synthesis and biological activity of amidinobicyclic compounds (derivatives of DX-9065a) as factor Xa inhibitors: SAR study of S1 and aryl binding sites. | Bioorganic & medicinal chemistry 20040501 |
Benzimidazole-based fXa inhibitors with improved thrombin and trypsin selectivity. | Bioorganic & medicinal chemistry letters 20020506 |
Probing inhibitors binding to human urokinase crystals by Raman microscopy: implications for compound screening. | Biochemistry 20010821 |
Species specificity of amidine-based urokinase inhibitors. | Biochemistry 20010807 |
© 2019 Angene International Limited. All rights Reserved.